Filed: 2/17/2026ACC: 0001104659-26-015410
📋 What this filing means
FORESITE CAPITAL MANAGEMENT V, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $164.40M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$164.40M
Total AUM (reported)
7.99M
Total Shares
Allocation by class
COM$155.53M94.6%
COM CL A$8.87M5.4%
Portfolio Concentration
Top 3$121.84M74.1%
4–10$42.56M25.9%
Top 3 weight
74.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.99M
Sole
Full voting authority
7.99M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
ALUMIS INC.
SOLEShares5.78M
TypeSH
Market value$56.41M
34.31%
Sole
5.78M
Shared
0.00
None
0.00
CG Oncology, Inc.
SOLEShares1M
TypeSH
Market value$41.69M
25.36%
Sole
1M
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares299.07K
TypeSH
Market value$23.75M
14.45%
Sole
299.07K
Shared
0.00
None
0.00
Natera, Inc.
SOLEShares67.36K
TypeSH
Market value$15.43M
9.39%
Sole
67.36K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares477.08K
TypeSH
Market value$14.68M
8.93%
Sole
477.08K
Shared
0.00
None
0.00
Hims & Hers Health, Inc.
SOLEShares273.15K
TypeSH
Market value$8.87M
5.39%
Sole
273.15K
Shared
0.00
None
0.00
Maze Therapeutics, Inc.
SOLEShares86.29K
TypeSH
Market value$3.58M
2.17%
Sole
86.29K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ALUMIS INC.SOLE | COM | 5.78M | SH | $56.41M 34.31% | 5.78M | 0.00 | 0.00 |
CG Oncology, Inc.SOLE | COM | 1M | SH | $41.69M 25.36% | 1M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | COM | 299.07K | SH | $23.75M 14.45% | 299.07K | 0.00 | 0.00 |
Natera, Inc.SOLE | COM | 67.36K | SH | $15.43M 9.39% | 67.36K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 477.08K | SH | $14.68M 8.93% | 477.08K | 0.00 | 0.00 |
Hims & Hers Health, Inc.SOLE | COM CL A | 273.15K | SH | $8.87M 5.39% | 273.15K | 0.00 | 0.00 |
Maze Therapeutics, Inc.SOLE | COM | 86.29K | SH | $3.58M 2.17% | 86.29K | 0.00 | 0.00 |